Cardinal Health Inc (CAH) Valuation

A valuation assessment using the GoodMoat framework reveals Cardinal Health is trading at a substantial premium to its estimated intrinsic value. The current price of $211.31 is 63% above the GoodMoat Target of $129.42. According to the framework's DCF-based Margin of Safety bands, this represents a deeply unfavourable situation, as the price exceeds the target by a wide margin, implying a negative margin of safety. The forward P/E of 30.2x must be contextualized against the company's very low profit margin of 0.7% and operating margin of 1.0%. While the P/E multiple itself is not extreme in absolute terms, it is high for a low-margin distribution business and suggests the market is pricing in significant future improvement. The 3.7% Free Cash Flow Yield, while positive, is not compelling enough to offset the valuation concerns when the stock price is so far above the estimated fair value. For a value investor seeking a margin of safety, the current price does not appear attractive based on this quantitative assessment. Analysis based on data as of 2024-05-15.